Category: Drug Discovery
Global Drug Discovery
-
Global Geographic Atrophy Market - 2023-2030
... forecast period 2023-2030. The Geographic Atrophy market is driven by factors such as increasing prevalence of the disease, increasing research and development, rising funding for research, and collaboration among key players. In Geographic Atrophy, the ... Read More
-
Global Liposarcoma Market - 2023-2030
... 2023-2030. The liposarcoma market is experiencing steady growth in recent years owing to the increasing prevalence and rising awareness. Liposarcoma typically affects more men and people assigned male at birth (AMAB) than women and people ... Read More
-
Global Scabies Treatment Market - 2023-2030
... period 2023-2030. The global scabies treatment market experiencing significant growth in recent years owing to the increasing prevalence of scabies. Scabies, an itchy skin rash mainly by sarcoptes scabiei var hominis. Globally, it is estimated ... Read More
-
Global Foveal Atrophy Market - 2023-2030
... forecast period 2023-2030. The Foveal atrophy market is driven by factors such as the aging population, advances in technology, increasing research and development, patient awareness and education, and regulatory approvals. A small, focal, poorly defined, ... Read More
-
Global Shigella Infections Market - 2023-2030
... forecast period 2023-2030. Shigellosis is a foodborne sickness that can be brought on by a genus of bacteria called Shigella. Shigellosis is characterized by symptoms like vomiting, fever, diarrhea (sometimes bloody), and abdominal pain. The ... Read More
-
Global Color Blindness Market - 2023-2030
... period 2023-2030. The color blindness market is experiencing significant growth in recent years owing to its increasing prevalence. Color blindness is also known as color vision deficiency usually inherited through a genetic mutation. There is ... Read More
-
Global Bacterial (Pyogenic) Meningitis Market - 2023-2030
... the forecast period 2023-2030. The global bacterial meningitis market has witnessed significant growth and transformations over the years, with various factors influencing its dynamics such as increasing prevalence and others. Government investments are boosting the ... Read More
-
Global Pharmaceutical and Life Science Outsourcing Services Market Professional Survey by Types, Applications, and Players, with Regional Growth Rate Analysis and Development Situation, from 2023 to 2028
... characteristics, and market growth of the Pharmaceutical and Life Science Outsourcing Services industry between the year 2018 to 2028, and breaks down according to the product type, downstream application, and consumption area of Pharmaceutical and ... Read More
-
Organoids Market Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Organ Type (Intestine, Liver, Stomach, Pancreas, Lung, Brain, Kidney, and Others), Application (Development of Biology Disease, Pathology of infectious Disease, Regenerative Medicines, Drug Discovery and Personalized Medicine, Drug Toxicity and Efficacy Testing, and Others), Source (Pluripotent Stem Cell and Organ Specific Adult Stem Cell), Type (Instruments, Consumables, and Services), and Geography
... Disease, Pathology of infectious Disease, Regenerative Medicines, Drug Discovery and Personalized Medicine, Drug Toxicity and Efficacy Testing, and Others), Source (Pluripotent Stem Cell and Organ Specific Adult Stem Cell), Type (Instruments, Consumables, and Services), and ... Read More
-
Global Epstein-Barr Virus Diagnosis and Treatment Market 2023-2030
... Other Drugs), Forecast Period (2023-2030) The global Epstein - Barr virus diagnosis and treatment market is anticipated to grow at a considerable CAGR of 5.1% during the forecast period (2023-2030). The considerable prevalence of the ... Read More
-
Growth Opportunities in the Global Digital Therapeutics Market
... (DTx) market and highlights key growth opportunities for global DTx market participants. Patients with long-term chronic conditions increasingly seek safe, evidence-based digital treatments to reduce their medication dosages, reverse triggers of adverse events, and limit ... Read More
-
Glycomic Therapeutics Global Market Report 2023 Including: 1) By Class: Isolated; Synthetic 2) By Structures: Glycoproteins; Targeting Sialic Acid; Proteoglycans; Targeting Glycosaminoglycans; Glycosylphosphatidylinositol (GPI)-Anchored Proteins And Heparin Based Glycans; Targeting Glycosphingolipids 3) By Mode Of Action: Inhibits Neuraminidase; Inhibits Heparanase And Selectins And Blocks Interactions Between Growth Factors And Heparan Sulfate; Erythropoietin And Enzyme Replacement Therapy (ERT); Tissue Plasminogen Activator; Inhibits Glucosylceramide Synthase; Interleukin 1, 2 And 3; Beta And Gamma Interferons 4) By Indications: Thrombosis And Chemoprophylaxis; Anemia; Anti-Adhesive And Anti-Inflammatory; Cataracts; Gaucher’s Disease; Mps-1 And IV; Cancer; Alzheimer’s Disease; Influenza Type A And B Covering: F Hoffmann-La Roche Ltd.; Bayer AG; Sanofi SA; Thermo Fisher Scientific Inc.; GlaxoSmithKline plc
... Neuraminidase; Inhibits Heparanase And Selectins And Blocks Interactions Between Growth Factors And Heparan Sulfate; Erythropoietin And Enzyme Replacement Therapy (ERT); Tissue Plasminogen Activator; Inhibits Glucosylceramide Synthase; Interleukin 1, 2 And 3; Beta And Gamma Interferons4) ... Read More
-
Medical Foods For Orphan Diseases Global Market Report 2023 Including: 1) By Product: Pills; Powder; Liquid 2) By Route of Administration: Oral; Enteral 3) By Applications: Phenylketonuria; Tyrosinemia; Eosinophilic esophagitis; Food Protein-Induced Enterocolitis Syndrome (FPIES); Maple Syrup Urine Disease (MSUD); Homocystinuria 4) By Sales Channel: Online Sales; Institutional Sales; Retail Sales Covering: Nestle S.A.; Johnson & Johnson; Abbott Laboratories Inc.; Danone S.A.; Reckitt Benckiser Group plc
... Urine Disease (MSUD); Homocystinuria4) By Sales Channel: Online Sales; Institutional Sales; Retail SalesCovering: Nestle S.A.; Johnson & Johnson; Abbott Laboratories Inc.; Danone S.A.; Reckitt Benckiser Group plc Medical Foods For Orphan Diseases Global Market Report ... Read More
-
Ewing Sarcoma Drugs Market - Global Ewing Sarcoma Drugs Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2030 - (By Tumour Type Coverage, By Application Coverage Coverage, By End User Coverage, By Geographic Coverage and By Company)
... Coverage and By Company) Ewing Sarcoma Drugs Market Gains Momentum with Expected 5% CAGR, Surpassing $0.3 Billion by 2030 The global Ewing sarcoma drugs market is on a trajectory of significant growth, with a promising ... Read More
-
Pharmaceutical Grade Lithium Carbonate Market by Application (Extended Release, Immediate Release), Purity (99%, Above 99%), and Region (Asia Pacific, Europe, North America, Middle East & Africa, and South America) - Global Forecast to 2028
... pharmaceutical grade lithium carbonate market is projected to grow from USD 141 million in 2023 to USD 166 million by 2028, at a CAGR of 3.3% from 2023 to 2028. Lithium carbonate is commonly used ... Read More
-
Global Liquid Dosage Excipients Growth Opportunities
... to 2030 across major regional markets, including North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. The oral liquid excipients market provides qualitative and quantitative analyses of different segments such as sweetening ... Read More
-
Global Bone Cancer Treatment Market - 2023-2030
... the forecast period 2023-2030. Bone cancer is characterized by the uncontrolled growth of cells in the bone. Different types of bone tissue give rise to different types of primary bone cancer. Osteosarcoma develops from cells ... Read More
-
Global Vulvodynia Pain Management Market - 2023-2030
... the forecast period 2023-2030. Vulvodynia is a chronic pain condition of the vulva (outer female genitals). It usually lasts over three months, and there's no known cause. Vulvodynia affects women of all age groups; the ... Read More
-
Global Pneumonia Therapeutics Market - 2023-2030
... period 2023-2030. Pneumonia is characterized by inflammation and fluid accumulation in the lungs which is caused by a bacterial, viral, or fungal infection. Bacterial pneumonia tends to be more common and more severe than viral ... Read More
-
Global Drug-Resistant Epilepsy Market - 2023-2030
... forecast period 2023-2030. A third of epileptics are thought to be affected by drug resistance, however the frequency of this condition varies depending on the epilepsy syndrome, the underlying cause, and other elements including the ... Read More
-
Global Herpes Zoster Infection Treatment Market - 2023-2030
... 3.6% during the forecast period 2023-2030. Ramsay Hunt Syndrome, also known as herpes zoster oticus, is a shingles-related disorder in which the facial nerve around one of the ears is involved. This is a neurological ... Read More
-
Global Non-Clinical Trials Market - 2023-2030
... period 2023-2030. By conducting non-clinical trials, researchers can identify and address safety issues early in the drug development process, reducing the risk of harm to human participants in later clinical trials. Non-clinical trials help determine ... Read More
-
Global Wilms Tumor Treatment Market - 2023-2030
... the forecast period 2023-2030. The trend such as the shift towards personalized medicine by better understanding of specific gene mutations associated with this tumor is expected to dominate the global wilms tumor treatment market. The ... Read More
-
Global Adenoid Cystic Carcinoma Market - 2023-2030
... the forecast period 2023-2030. The trend such as shift towards personalized medicine is expected to dominate the global adenoid cystic carcinoma market. The global adenoid cystic carcinoma (ACC) market has grown significantly in recent years ... Read More
-
Global Markets for Treatments for Syndromes of Progressive Ataxia and Weakness Disorders
... analyzes each market and its applications, the technologies involved, market projections and market shares. Technological issues include the latest trends and developments. The emerging market for enzyme inhibitors includes India, China, Japan, Canada and Australia. ... Read More
Research Assistance
